ArticleNeural regeneration research2018

Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury.

Shelly A Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.